ONC201: Stressing tumors to death

Science Signaling

Volumn 9, Issue 415, 2016, Pages

  Greer, Yoshimi Endo ^a   Lipkowitz, Stanley ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; ANTINEOPLASTIC AGENT; CALCIUM ION; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 34; INITIATION FACTOR 2ALPHA; MITOGEN ACTIVATED PROTEIN KINASE; ONC 201; PROTEIN; PROTEIN KINASE B; TRANSCRIPTION FACTOR; TRIBBLES HOMOLOG 3 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ACUTE MYELOBLASTIC LEUKEMIA; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; BINDING SITE; CANCER INHIBITION; CELL HYPOXIA; COLON CANCER; DNA DAMAGE; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG EFFICACY; ENDOPLASMIC RETICULUM STRESS; ENZYME INACTIVATION; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GROWTH INHIBITION; MANTLE CELL LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SOLID TUMOR; TRANSCRIPTION INITIATION; UNFOLDED PROTEIN RESPONSE; UPREGULATION; HEMATOLOGIC DISEASE; HUMAN; METABOLISM; NEOPLASM;

HEMATOLOGIC NEOPLASMS; HUMANS; NEOPLASMS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND;

EID: 84959104620     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.aad7955     Document Type: Article

References (16)

1. M. Rahman, J. G. Pumphrey, S. Lipkowitz, The TRAIL to targeted therapy of breast cancer. Adv. Cancer Res. 103, 43-73 (2009).
2. R. W. Johnstone, A. J. Frew, M. J. Smyth, The TRAIL apoptotic pathway in cancer onset, progression and therapy. Nat. Rev. Cancer 8, 782-798 (2008).
3. A. Ashkenazi, G. Salvesen, Regulated cell death: Signaling andmechanisms.Annu.Rev.CellDev.Biol. 30, 337-356 (2014).
4. A. Ashkenazi, Targeting the extrinsic apoptotic pathway in cancer: Lessons learned and future directions. J. Clin. Invest. 125, 487-489 (2015).
5. M. W. den Hollander, J. A. Gietema, S. de Jong, A. M. Walenkamp, A. K. Reyners, C. N. Oldenhuis, E. G. de Vries, Translating TRAIL-receptor targeting agents to the clinic. Cancer Lett. 332, 194-201 (2013).
6. J. Abdulghani, W. S. El-Deiry, TRAIL receptor signaling and therapeutics. ExpertOpin.Ther. Targets 14, 1091-1108 (2010).
7. J. E. Allen, G. Krigsfeld, P. A. Mayes, L. Patel, D. T. Dicker, A. S. Patel, N. G. Dolloff, E.Messaris, K. A. Scata, W. Wang, J. Y. Zhou, G. S. Wu, W. S. El-Deiry, Dual inactivation of Akt and ERK by TIC10 signals Foxo3a nuclear translocation, TRAIL gene induction, and potent antitumor effects. Sci. Transl. Med. 5, 171ra17 (2013).
8. J. E. Allen, G. Krigsfeld, L. Patel, P. A. Mayes, D. T. Dicker, G. S. Wu, W. S. El-Deiry, Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway. Mol. Cancer 14, 99 (2015).
9. M. K. Talekar, J.E. Allen, D. T.Dicker, W. S.El-Deiry, ONC201 induces cell death in pediatric non-Hodgkin's lymphoma cells. Cell Cycle 14, 2422-2428 (2015).
10. J. Ishizawa, K. Kojima, D. Chachad, P. Ruvolo, V. Ruvolo, R. O. Jacamo, G. Borthakur, H. Mu, Z. Zeng, Y. Tabe, J. E. Allen, Z. Wang, W. Ma, H.C. Lee, R.Orlowski, D.D. Sarbassov, P. L. Lorenzi, X. Huang, S. S. Neelapu, T.McDonnell, R. N.Miranda, M. Wang, H. Kantarjian, M. Konopleva, R. E. Davis, M. Andreeff, ATF4 induction through an atypical integrated stress response to ONC201 triggers p53-independent apoptosis in hematological malignancies. Sci. Signal. 9, ra17 (2016).
11. I. Kim, W. Xu, J. C. Reed, Cell death and endoplasmic reticulum stress: Disease relevance and therapeutic opportunities. Nat. Rev. Drug Discov. 7, 1013-1030 (2008). doi
12. F. Tameire, I. I. Verginadis II, C. Koumenis, Cell intrinsic and extrinsic activators of the unfolded protein response in cancer:Mechanisms and targets for therapy. Semin. Cancer Biol. 33, 3-15 (2015).
13. N. Donnelly, A. M. Gorman, S. Gupta, A. Samali, The eIF2a kinases: Their structures and functions. Cell. Mol. Life Sci. 70, 3493-3511 (2013).
14. H. P. Harding, Y. Zhang, H. Zeng, I. Novoa, P. D. Lu, M. Calfon, N. Sadri, C. Yun, B. Popko, R. Paules, D. F. Stojdl, J. C. Bell, T. Hettmann, J. M. Leiden, D. Ron, An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. Mol. Cell 11, 619-633 (2003).
15. S. Oyadomari, M. Mori, Roles of CHOP/GADD153 in endoplasmic reticulum stress. Cell Death Differ. 11, 381-389 (2004).
16. C. L. B. Kline, A. P. J. Van den Heuvel, J. E. Allen, V. V. Prabhu, D. T. Dicker, W. S. El-Deiry, ONC201 kills solid tumor cells by triggering an integrated stress response dependent on ATF4 activation by specific eIF2a kinases. Sci. Signal. 9, ra18 (2016).